25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

RENB (Renovaro Biosciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Renovaro Biosciences Inc together

I guess you are interested in Renovaro Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Renovaro Biosciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Renovaro Biosciences Inc’s Price Targets

I'm going to help you getting a better view of Renovaro Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Renovaro Biosciences Inc

I send you an email if I find something interesting about Renovaro Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Renovaro Biosciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Renovaro Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.57
Expected worth in 1 year
$0.57
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.19
Expected price per share
$0.182 - $0.264
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Renovaro Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)
$0.19
Intrinsic Value Per Share
$-0.59 - $-0.06
Total Value Per Share
$-0.02 - $0.52

2.2. Growth of Renovaro Biosciences Inc (5 min.)




Is Renovaro Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$131.9m$131.9m0.000.0%

How much money is Renovaro Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$80.6m-$80.6m1.000.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Renovaro Biosciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Renovaro Biosciences Inc?

Welcome investor! Renovaro Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Renovaro Biosciences Inc.

First you should know what it really means to hold a share of Renovaro Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Renovaro Biosciences Inc is $0.1907. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Renovaro Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Renovaro Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.57. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Renovaro Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.35-183.1%-0.35-183.1%-0.35-183.1%-0.29-152.1%-0.30-154.9%-0.16-86.5%
Usd Book Value Change Per Share0.000.0%0.000.0%0.37194.1%0.0944.9%-0.03-15.6%0.0629.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.37194.1%0.0944.9%-0.03-15.6%0.0629.2%
Usd Price Per Share0.29-0.29-1.75-0.87-1.90-2.34-
Price to Earnings Ratio-0.83--0.83--5.01--3.05--11.20--52.51-
Price-to-Total Gains Ratio4.73--0.14-33.03-33.64-
Price to Book Ratio0.51-0.51-3.06-2.13-3.82-32.20-
Price-to-Total Gains Ratio4.73--0.14-33.03-33.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1907
Number of shares5243
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.03
Usd Total Gains Per Share0.00-0.03
Gains per Quarter (5243 shares)0.00-155.73
Gains per Year (5243 shares)0.00-622.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-100-623-633
200-100-1246-1256
300-100-1869-1879
400-100-2492-2502
500-100-3115-3125
600-100-3737-3748
700-100-4360-4371
800-100-4983-4994
900-100-5606-5617
1000-100-6229-6240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.014.00.00.0%
Book Value Change Per Share0.00.01.00.0%1.01.01.033.3%2.02.01.040.0%5.04.01.050.0%6.07.01.042.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.014.00.0%
Total Gains per Share0.00.01.00.0%1.01.01.033.3%2.02.01.040.0%5.04.01.050.0%6.07.01.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Renovaro Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%0.370-100%0.086-100%-0.0300%0.056-100%
Book Value Per Share--0.5720.5720%0.5720%0.448+28%0.483+18%0.458+25%
Current Ratio--0.0660.0660%0.0660%0.122-46%2.586-97%5.081-99%
Debt To Asset Ratio--0.1910.1910%0.1910%0.195-2%0.161+19%0.343-44%
Debt To Equity Ratio--0.2360.2360%0.2360%0.242-2%0.195+21%0.319-26%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--35806639.68835806639.6880%373193897.000-90%176640232.852-80%425242238.871-92%593134651.213-94%
Eps---0.349-0.3490%-0.3490%-0.290-17%-0.295-15%-0.165-53%
Ev To Ebitda Ratio---0.439-0.4390%-4.693+968%-3.780+760%-16.079+3561%-61.106+13811%
Free Cash Flow Per Share---0.048-0.0480%-0.0480%-0.049+2%-0.061+27%-0.042-12%
Free Cash Flow To Equity Per Share---0.002-0.0020%-0.0020%-0.012+430%-0.007+201%0.003-185%
Gross Profit Margin--1.0051.0050%1.0050%1.003+0%1.002+0%1.001+0%
Intrinsic Value_10Y_max---0.055----------
Intrinsic Value_10Y_min---0.592----------
Intrinsic Value_1Y_max---0.034----------
Intrinsic Value_1Y_min---0.061----------
Intrinsic Value_3Y_max---0.081----------
Intrinsic Value_3Y_min---0.183----------
Intrinsic Value_5Y_max---0.101----------
Intrinsic Value_5Y_min---0.304----------
Market Cap44038158.774-52%66738478.68866738478.6880%404125736.000-83%200569527.185-67%439023725.271-85%541195948.492-88%
Net Profit Margin----0%-0%-0%-0%-4.0570%
Operating Margin----0%-0%-0%-0%-5.1340%
Operating Ratio----0%-0%-0%-0%5.059-100%
Pb Ratio0.334-52%0.5060.5060%3.062-83%2.127-76%3.818-87%32.203-98%
Pe Ratio-0.546+34%-0.828-0.8280%-5.011+506%-3.045+268%-11.202+1254%-52.508+6245%
Price Per Share0.191-52%0.2890.2890%1.750-83%0.869-67%1.901-85%2.344-88%
Price To Free Cash Flow Ratio-3.988+34%-6.044-6.0440%-36.599+506%-17.909+196%-27.520+355%-88.975+1372%
Quick Ratio--0.0440.0440%0.0440%0.086-49%2.528-98%5.010-99%
Return On Assets---0.494-0.4940%-0.4940%-0.556+13%-0.630+27%-0.582+18%
Return On Equity---0.611-0.6110%-0.6110%-0.692+13%-0.758+24%-0.540-12%
Total Gains Per Share----0%0.370-100%0.086-100%-0.0300%0.056-100%
Usd Book Value--131977144.000131977144.0000%131977144.0000%103485466.333+28%111547637.200+18%105674345.400+25%
Usd Book Value Change Per Share----0%0.370-100%0.086-100%-0.0300%0.056-100%
Usd Book Value Per Share--0.5720.5720%0.5720%0.448+28%0.483+18%0.458+25%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--35806639.68835806639.6880%373193897.000-90%176640232.852-80%425242238.871-92%593134651.213-94%
Usd Eps---0.349-0.3490%-0.3490%-0.290-17%-0.295-15%-0.165-53%
Usd Free Cash Flow---11041860.000-11041860.0000%-11041860.0000%-11296014.333+2%-14057030.000+27%-9717108.100-12%
Usd Free Cash Flow Per Share---0.048-0.0480%-0.0480%-0.049+2%-0.061+27%-0.042-12%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%-0.0020%-0.012+430%-0.007+201%0.003-185%
Usd Market Cap44038158.774-52%66738478.68866738478.6880%404125736.000-83%200569527.185-67%439023725.271-85%541195948.492-88%
Usd Price Per Share0.191-52%0.2890.2890%1.750-83%0.869-67%1.901-85%2.344-88%
Usd Profit---80650172.000-80650172.0000%-80650171.0000%-66994799.667-17%-68228279.600-15%-38076414.000-53%
Usd Revenue----0%-0%-0%-0%4276.900-100%
Usd Total Gains Per Share----0%0.370-100%0.086-100%-0.0300%0.056-100%
 EOD+2 -5MRQTTM+0 -0YOY+3 -173Y+16 -165Y+14 -1410Y+11 -23

3.3 Fundamental Score

Let's check the fundamental score of Renovaro Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.546
Price to Book Ratio (EOD)Between0-10.334
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.044
Current Ratio (MRQ)Greater than10.066
Debt to Asset Ratio (MRQ)Less than10.191
Debt to Equity Ratio (MRQ)Less than10.236
Return on Equity (MRQ)Greater than0.15-0.611
Return on Assets (MRQ)Greater than0.05-0.494
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Renovaro Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.350
Ma 20Greater thanMa 500.223
Ma 50Greater thanMa 1000.257
Ma 100Greater thanMa 2000.293
OpenGreater thanClose0.219
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Renovaro Biosciences Inc

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company has a strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The company was formerly known as Renovaro Biosciences Inc. and changed its name to Renovaro Inc. in February 2024. Renovaro Inc. is headquartered in Los Angeles, California.

Fundamental data was last updated by Penke on 2025-08-20 18:17:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Renovaro Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Renovaro Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-405.7%+405.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--85.5%+85.5%
TTM--168.0%+168.0%
YOY--210.0%+210.0%
3Y--289.9%+289.9%
5Y--382.7%+382.7%
10Y-405.7%-520.3%+114.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Renovaro Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • -49.4% Return on Assets means thatΒ Renovaro Biosciences Inc generatedΒ $-0.49 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Renovaro Biosciences Inc:

  • The MRQ is -49.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -49.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.4%TTM-49.4%0.0%
TTM-49.4%YOY-49.4%0.0%
TTM-49.4%5Y-63.0%+13.6%
5Y-63.0%10Y-58.2%-4.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.4%-11.9%-37.5%
TTM-49.4%-12.0%-37.4%
YOY-49.4%-11.3%-38.1%
3Y-55.6%-12.0%-43.6%
5Y-63.0%-11.7%-51.3%
10Y-58.2%-13.8%-44.4%
4.3.1.3. Return on Equity

Shows how efficient Renovaro Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • -61.1% Return on Equity means Renovaro Biosciences Inc generated $-0.61Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Renovaro Biosciences Inc:

  • The MRQ is -61.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -61.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-61.1%TTM-61.1%0.0%
TTM-61.1%YOY-61.1%0.0%
TTM-61.1%5Y-75.8%+14.7%
5Y-75.8%10Y-54.0%-21.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.1%-14.2%-46.9%
TTM-61.1%-15.1%-46.0%
YOY-61.1%-15.1%-46.0%
3Y-69.2%-16.9%-52.3%
5Y-75.8%-17.5%-58.3%
10Y-54.0%-19.7%-34.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Renovaro Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Renovaro Biosciences Inc is operatingΒ .

  • Measures how much profit Renovaro Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Renovaro Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-513.4%+513.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM--270.5%+270.5%
YOY--254.3%+254.3%
3Y--276.4%+276.4%
5Y--350.8%+350.8%
10Y-513.4%-532.3%+18.9%
4.3.2.2. Operating Ratio

Measures how efficient Renovaro Biosciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Renovaro Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y5.059-5.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.891-1.891
TTM-2.917-2.917
YOY-3.080-3.080
3Y-3.835-3.835
5Y-4.924-4.924
10Y5.0596.864-1.805
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Renovaro Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Renovaro Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.07Β means the company has $0.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Renovaro Biosciences Inc:

  • The MRQ is 0.066. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.066. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.0660.000
TTM0.066YOY0.0660.000
TTM0.0665Y2.586-2.520
5Y2.58610Y5.081-2.495
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0663.480-3.414
TTM0.0663.795-3.729
YOY0.0664.104-4.038
3Y0.1224.607-4.485
5Y2.5865.762-3.176
10Y5.0816.164-1.083
4.4.3.2. Quick Ratio

Measures if Renovaro Biosciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.04Β means the company can pay off $0.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Renovaro Biosciences Inc:

  • The MRQ is 0.044. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.044. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.044TTM0.0440.000
TTM0.044YOY0.0440.000
TTM0.0445Y2.528-2.484
5Y2.52810Y5.010-2.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0442.952-2.908
TTM0.0443.302-3.258
YOY0.0443.927-3.883
3Y0.0864.393-4.307
5Y2.5285.875-3.347
10Y5.0106.549-1.539
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Renovaro Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Renovaro Biosciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Renovaro Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19Β means that Renovaro Biosciences Inc assets areΒ financed with 19.1% credit (debt) and the remaining percentage (100% - 19.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Renovaro Biosciences Inc:

  • The MRQ is 0.191. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.191. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.191TTM0.1910.000
TTM0.191YOY0.1910.000
TTM0.1915Y0.161+0.030
5Y0.16110Y0.343-0.182
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1910.340-0.149
TTM0.1910.355-0.164
YOY0.1910.335-0.144
3Y0.1950.341-0.146
5Y0.1610.349-0.188
10Y0.3430.379-0.036
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Renovaro Biosciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 23.6% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Renovaro Biosciences Inc:

  • The MRQ is 0.236. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.236. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.236TTM0.2360.000
TTM0.236YOY0.2360.000
TTM0.2365Y0.195+0.041
5Y0.19510Y0.319-0.123
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2360.393-0.157
TTM0.2360.436-0.200
YOY0.2360.436-0.200
3Y0.2420.461-0.219
5Y0.1950.459-0.264
10Y0.3190.514-0.195
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Renovaro Biosciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Renovaro Biosciences Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.83 means the investor is paying $-0.83Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Renovaro Biosciences Inc:

  • The EOD is -0.546. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.828. Based on the earnings, the company is expensive. -2
  • The TTM is -0.828. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.546MRQ-0.828+0.281
MRQ-0.828TTM-0.8280.000
TTM-0.828YOY-5.011+4.183
TTM-0.8285Y-11.202+10.375
5Y-11.20210Y-52.508+41.305
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.546-2.537+1.991
MRQ-0.828-2.362+1.534
TTM-0.828-2.678+1.850
YOY-5.011-3.833-1.178
3Y-3.045-3.900+0.855
5Y-11.202-6.480-4.722
10Y-52.508-7.170-45.338
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Renovaro Biosciences Inc:

  • The EOD is -3.988. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.044. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.044. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.988MRQ-6.044+2.056
MRQ-6.044TTM-6.0440.000
TTM-6.044YOY-36.599+30.555
TTM-6.0445Y-27.520+21.476
5Y-27.52010Y-88.975+61.454
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.988-3.385-0.603
MRQ-6.044-3.040-3.004
TTM-6.044-3.676-2.368
YOY-36.599-4.421-32.178
3Y-17.909-5.258-12.651
5Y-27.520-8.587-18.933
10Y-88.975-9.639-79.336
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Renovaro Biosciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.51 means the investor is paying $0.51Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Renovaro Biosciences Inc:

  • The EOD is 0.334. Based on the equity, the company is cheap. +2
  • The MRQ is 0.506. Based on the equity, the company is cheap. +2
  • The TTM is 0.506. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.334MRQ0.506-0.172
MRQ0.506TTM0.5060.000
TTM0.506YOY3.062-2.556
TTM0.5065Y3.818-3.312
5Y3.81810Y32.203-28.385
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3342.199-1.865
MRQ0.5061.995-1.489
TTM0.5062.190-1.684
YOY3.0622.415+0.647
3Y2.1272.574-0.447
5Y3.8183.805+0.013
10Y32.2034.462+27.741
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Renovaro Biosciences Inc.

4.8.1. Institutions holding Renovaro Biosciences Inc

Institutions are holding 12.18% of the shares of Renovaro Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc3.18650.0001735854085694013.1804
2025-06-30Vanguard Group Inc2.132504924629-735704-12.9975
2025-03-31Geode Capital Management, LLC1.02530.00012367658350241.5015
2025-03-31State Street Corp0.867402003190-61669-2.9866
2025-03-31Northern Trust Corp0.36040.0001832288-57069-6.4169
2025-03-31UBS Group AG0.30480.0001703840-59861-7.8383
2025-06-30Goldman Sachs Group Inc0.25760594988412934226.8195
2025-03-31Bank of New York Mellon Corp0.1040240244163297.2925
2025-03-31Morgan Stanley - Brokerage Accounts0.09040208681-159483-43.3185
2025-03-31Citadel Advisors Llc0.071901660831660830
2025-03-31Deutsche Bank AG0.068501581703073324.1162
2025-03-31Nuveen, LLC0.065701516811516810
2025-03-31Susquehanna International Group, LLP0.0601013877177045124.8177
2025-03-31JPMorgan Chase & Co0.05590128982-224851-63.5472
2025-03-31Rhumbline Advisers0.05330.0001123006100468.8934
2025-03-31Barclays PLC0.05190119828-60016-33.3711
2025-03-31Commonwealth Equity Services Inc0.0440.000110157300
2025-03-31MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.0.02940.00016786229394.5269
2025-03-31ING Investment Management LLC0.02880665083119688.3439
2025-03-31Wells Fargo & Co0.02570593162150.3638
Total 8.88410.000720515838+432512+2.1%

4.9.2. Funds holding Renovaro Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Vanguard Total Stock Mkt Idx Inv1.44720.0001334190000
2025-06-30Vanguard Institutional Extnd Mkt Idx Tr0.60830.0004140470800
2025-05-31Fidelity Small Cap Index0.49130.0014113458700
2025-06-30Fidelity Extended Market Index0.21070.0004486467-1270-0.2604
2025-06-30Extended Equity Market Fund K0.07630.0004176231-3517-1.9566
2025-06-30Fidelity Total Market Index0.0662015279100
2025-06-30Fidelity Series Total Market Index0.0558012891200
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.04920.00051136812676730.7971
2025-05-31Spartan Small Cap Index Pool K0.0450.001410387200
2025-06-30Spartan Extended Market Index Pool F0.04180.00039652000
2025-06-30NT Ext Equity Mkt Idx Fd - L0.04150.00049590100
2025-06-30Northern Trust Extended Eq Market Idx0.04150.00049590100
2025-06-30Fidelity Nasdaq Composite Index0.04010.00019258200
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03820.0005882732061630.4713
2025-06-30Goldman Sachs Absolute Ret Trckr Instl0.03670.00048482372273575.8805
2025-06-30Vanguard Balanced Index Inv0.030407023900
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.02790.00026444200
2025-06-30Vanguard Instl Ttl Stk Mkt Idx InstlPls0.02790.00016444200
2025-06-30Spartan Total Market Index Pool G0.024805727900
2025-06-30iShares Russell 2000 Small-Cap Idx Instl0.02110.000348821-150421-75.4966
Total 3.42190.00737902372-35552-0.4%

5.3. Insider Transactions

Insiders are holding 36.714% of the shares of Renovaro Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-07-29Anderson Wittekind WilliamSELL11141.3
2024-07-17Anderson Wittekind WilliamSELL163621.46
2024-07-15Anderson Wittekind WilliamSELL219541.41
2024-07-11Anderson Wittekind WilliamSELL148961.51
2024-07-09Anderson Wittekind WilliamSELL46301.53
2024-07-05Anderson Wittekind WilliamSELL600001.55
2024-07-03Anderson Wittekind WilliamSELL500001.51
2024-07-01Anderson Wittekind WilliamSELL600001.56
2024-06-27Anderson Wittekind WilliamSELL146711.5
2024-06-25Anderson Wittekind WilliamSELL200001.58
2024-06-14Anderson Wittekind WilliamSELL500001.58
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets163,129
Total Liabilities31,152
Total Stockholder Equity131,977
 As reported
Total Liabilities 31,152
Total Stockholder Equity+ 131,977
Total Assets = 163,129

Assets

Total Assets163,129
Total Current Assets1,998
Long-term Assets161,132
Total Current Assets
Cash And Cash Equivalents 220
Net Receivables 1,108
Other Current Assets 669
Total Current Assets  (as reported)1,998
Total Current Assets  (calculated)1,998
+/-0
Long-term Assets
Property Plant Equipment 1,752
Goodwill 159,330
Intangible Assets 30
Long-term Assets Other 20
Long-term Assets  (as reported)161,132
Long-term Assets  (calculated)161,132
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities30,310
Long-term Liabilities842
Total Stockholder Equity131,977
Total Current Liabilities
Short-term Debt 2,945
Accounts payable 9,449
Other Current Liabilities 17,685
Total Current Liabilities  (as reported)30,310
Total Current Liabilities  (calculated)30,079
+/- 231
Long-term Liabilities
Long-term Liabilities  (as reported)842
Long-term Liabilities  (calculated)0
+/- 842
Total Stockholder Equity
Common Stock16
Retained Earnings -332,455
Other Stockholders Equity 456,811
Total Stockholder Equity (as reported)131,977
Total Stockholder Equity (calculated)124,372
+/- 7,605
Other
Cash and Short Term Investments 220
Common Stock Shares Outstanding 96,248
Liabilities and Stockholders Equity 163,129
Net Debt 3,566
Net Working Capital -28,312
Short Long Term Debt Total 3,787



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-30
> Total Assets 
0
14
20
500
5,240
871
4,522
182,502
179,877
178,102
189,605
84,633
58,301
163,129
163,129
163,129163,12958,30184,633189,605178,102179,877182,5024,5228715,24050020140
   > Total Current Assets 
0
14
20
100
5,046
732
4,199
15,762
12,495
8,941
20,899
9,565
2,565
1,998
1,998
1,9981,9982,5659,56520,8998,94112,49515,7624,1997325,04610020140
       Cash And Cash Equivalents 
0
0
7
0
3,009
23
3,942
15,601
12,282
8,696
20,664
9,172
1,874
220
220
2202201,8749,17220,6648,69612,28215,6013,942233,0090700
       Short-term Investments 
0
0
0
0
2,030
0
0
0
0
0
0
0
0
0
0
00000000002,0300000
       Net Receivables 
0
13
13
0
8
695
224
123
21
2
2
0
0
1,108
1,108
1,1081,1080022211232246958013130
       Other Current Assets 
0
0
0
0
2,030
14
33
38
192
245
233
393
691
669
669
6696696913932332451923833142,0300000
   > Long-term Assets 
0
0
0
400
194
138
323
166,740
167,382
169,161
168,706
75,068
55,735
161,132
161,132
161,132161,13255,73575,068168,706169,161167,382166,740323138194400000
       Property Plant Equipment 
0
0
0
0
0
0
0
27
688
2,482
2,155
1,744
1,423
1,752
1,752
1,7521,7521,4231,7442,1552,482688270000000
       Goodwill 
0
0
0
0
0
0
0
11,640
11,640
11,640
11,640
11,640
11,640
159,330
159,330
159,330159,33011,64011,64011,64011,64011,64011,6400000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000
       Intangible Assets 
0
0
0
200
186
136
124
152,095
154,917
154,901
154,890
61,615
42,651
30
30
303042,65161,615154,890154,901154,917152,095124136186200000
       Other Assets 
0
0
0
0
3
3
199
138
138
138
21
69
22
0
0
00226921138138138199330000
> Total Liabilities 
9
27
71
2,100
1,758
1,508
2,989
23,765
6,777
11,830
14,942
12,014
11,799
31,152
31,152
31,15231,15211,79912,01414,94211,8306,77723,7652,9891,5081,7582,10071279
   > Total Current Liabilities 
9
27
71
2,100
1,758
1,508
2,989
874
1,110
1,335
1,886
6,451
11,023
30,310
30,310
30,31030,31011,0236,4511,8861,3351,1108742,9891,5081,7582,10071279
       Short-term Debt 
0
27
64
0
100
103
2,090
0
0
271
292
1,454
5,003
2,945
2,945
2,9452,9455,0031,454292271002,090103100064270
       Short Long Term Debt 
0
0
0
0
0
103
2,090
0
0
0
0
1,200
4,625
2,451
0
02,4514,6251,20000002,09010300000
       Accounts payable 
0
0
0
0
924
1,185
435
807
539
593
321
1,402
5,297
9,449
9,449
9,4499,4495,2971,4023215935398074351,1859240000
       Other Current Liabilities 
9
22
7
0
734
220
465
67
572
471
1,273
3,595
723
17,917
17,685
17,68517,9177233,5951,2734715726746522073407229
   > Long-term Liabilities 
0
5
64
0
1,024
1,288
2,760
22,891
5,667
10,495
13,056
5,563
776
842
842
8428427765,56313,05610,4955,66722,8912,7601,2881,02406450
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
5,781
0
0
0
0
0
000005,781000000000
       Other Liabilities 
0
0
0
0
0
0
0
22,891
5,667
3,182
6,038
0
0
0
0
00006,0383,1825,66722,8910000000
> Total Stockholder Equity
-9
-14
-51
0
3,482
-637
1,533
158,738
173,100
166,272
174,663
72,619
46,502
131,977
131,977
131,977131,97746,50272,619174,663166,272173,100158,7381,533-6373,4820-51-14-9
   Common Stock
1
1
1
0
1
1
1
4
5
5
5
5
6
16
16
16166555541110111
   Retained Earnings -332,455-324,679-244,029-204,345-90,912-64,188-52,772-34,755-28,444-26,301-21,892-19,500-76-39-9
   Capital Surplus 
0
0
0
0
25,098
25,098
29,872
193,284
225,765
230,497
0
0
0
0
0
00000230,497225,765193,28429,87225,09825,0980000
   Treasury Stock000000000000000
   Other Stockholders Equity 
-1
25
25
0
25,098
25,098
29,622
193,284
225,765
230,497
265,580
276,989
290,555
456,812
456,811
456,811456,812290,555276,989265,580230,497225,765193,28429,62225,09825,09802525-1



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit-1220
 
Operating Income (+$)
Gross Profit-122
Operating Expense-81,639
Operating Income-81,639-81,761
 
Operating Expense (+$)
Research Development2,709
Selling General Administrative24,174
Selling And Marketing Expenses384
Operating Expense81,63927,266
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,011
Other Finance Cost-1,011
Net Interest Income0
 
Pretax Income (+$)
Operating Income-81,639
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-80,650-82,628
EBIT - interestExpense = -82,651
-80,650
-79,639
Interest Expense1,011
Earnings Before Interest and Taxes (EBIT)-81,639-79,639
Earnings Before Interest and Taxes (EBITDA)-81,517
 
After tax Income (+$)
Income Before Tax-80,650
Tax Provision-0
Net Income From Continuing Ops0-80,650
Net Income-80,650
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses81,639
Total Other Income/Expenses Net9890
 

Technical Analysis of Renovaro Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Renovaro Biosciences Inc. The general trend of Renovaro Biosciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Renovaro Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Renovaro Biosciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Renovaro Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.22 < 0.223 < 0.264.

The bearish price targets are: 0.182.

Know someone who trades $RENB? Share this with them.πŸ‘‡

Renovaro Biosciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Renovaro Biosciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Renovaro Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Renovaro Biosciences Inc. The current macd is -0.01674919.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renovaro Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Renovaro Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Renovaro Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Renovaro Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartRenovaro Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Renovaro Biosciences Inc. The current adx is 16.48.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Renovaro Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Renovaro Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Renovaro Biosciences Inc. The current sar is 0.23025519.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Renovaro Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Renovaro Biosciences Inc. The current rsi is 36.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Renovaro Biosciences Inc Daily Relative Strength Index (RSI) ChartRenovaro Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Renovaro Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renovaro Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Renovaro Biosciences Inc Daily Stochastic Oscillator ChartRenovaro Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Renovaro Biosciences Inc. The current cci is -105.09767754.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Renovaro Biosciences Inc Daily Commodity Channel Index (CCI) ChartRenovaro Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Renovaro Biosciences Inc. The current cmo is -30.97879657.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Renovaro Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartRenovaro Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Renovaro Biosciences Inc. The current willr is -89.51807229.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Renovaro Biosciences Inc Daily Williams %R ChartRenovaro Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Renovaro Biosciences Inc.

Renovaro Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Renovaro Biosciences Inc. The current atr is 0.02255697.

Renovaro Biosciences Inc Daily Average True Range (ATR) ChartRenovaro Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Renovaro Biosciences Inc. The current obv is -34,636,770.

Renovaro Biosciences Inc Daily On-Balance Volume (OBV) ChartRenovaro Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Renovaro Biosciences Inc. The current mfi is 39.81.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Renovaro Biosciences Inc Daily Money Flow Index (MFI) ChartRenovaro Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Renovaro Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Renovaro Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Renovaro Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.350
Ma 20Greater thanMa 500.223
Ma 50Greater thanMa 1000.257
Ma 100Greater thanMa 2000.293
OpenGreater thanClose0.219
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Renovaro Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Renovaro Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Renovaro Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Renovaro Biosciences Inc

I send you an email if I find something interesting about Renovaro Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Renovaro Biosciences Inc.

Receive notifications about Renovaro Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.